065950 Stock Chart & Stats
₩1004.00
-₩26.00(-2.52%)
―
--
Day’s Range― - ―
52-Week Range₩911.00 - ₩2,220.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)541.11K
Market Cap
₩27.36B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.18
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding28,231,302
10 Day Avg. Volume1,500,149
30 Day Avg. Volume541,106
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
065950 FAQ
What was Welcron Co., Ltd’s price range in the past 12 months?
Welcron Co., Ltd lowest stock price was ₩911.00 and its highest was ₩2220.00 in the past 12 months.
What is Welcron Co., Ltd’s market cap?
Welcron Co., Ltd’s market cap is ₩27.36B.
When is Welcron Co., Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Welcron Co., Ltd’s earnings last quarter?
Currently, no data Available
Is Welcron Co., Ltd overvalued?
According to Wall Street analysts Welcron Co., Ltd’s price is currently Undervalued.
Does Welcron Co., Ltd pay dividends?
Welcron Co., Ltd does not currently pay dividends.
What is Welcron Co., Ltd’s EPS estimate?
Welcron Co., Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Welcron Co., Ltd have?
Welcron Co., Ltd has 28,231,302 shares outstanding.
What happened to Welcron Co., Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Welcron Co., Ltd?
Currently, no hedge funds are holding shares in KR:065950
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Genematrix Inc.
―
SANIGEN Co., Ltd.
―
Precision Biosensor, Inc.
―
NGeneBio Co., Ltd.
―
Genesystem Co., Ltd.
―